Matt Slein

PhD Candidate @Dartmouth in the Leib and Ackerman Labs / @BostonCollege ‘17/ formerly @RagonInstitute he/him 🏳️‍🌈

[bioRxiv Immunology @biorxiv_immuno]

Improving antibody-mediated protection against HSV infection by eliminating interactions with the viral Fc receptor gE/gI https://t.co/m5KJyH2zpw #biorxiv_immuno

[bioRxiv Immunology @biorxiv_immuno]

Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restriction. https://t.co/GggZThpCoP #biorxiv_immuno

[GOLD-UE @GOLDartmouth]

We just got word that an anonymous donor has agreed to match ALL DONATIONS THIS WEEK up to $10,000!!! Thank you so much to our generous donor and remember to donate to our Strike Fund ❤️:

https://t.co/nR3iB8MTMG

[Bernie Sanders @BernieSanders]

It is outrageous that while Dartmouth has an endowment of $7.9 billion, their graduate workers are struggling to get by. I stand in solidarity with 800 workers of @GOLDartmouth striking for a living wage and decent benefits.
https://t.co/sVRXuC305u

[José Delgado, Ph.D. @jmdelgado_]

Posting this the same day your grad student workers initiate a strike and arrest peaceful protestors is comical.

[Matt Slein @mattslein]

@DTP_PhD Congrats!!!!

[Matt Slein @mattslein]

Hallo Berlin!

[Matt Slein @mattslein]

@DTPtoPhD @LazearLab @nigelmgo Congrats!!!

[Cell Reports Medicine @CellRepMed]

Online now: Effector functions are required for broad and potent protection of neonatal mice with antibodies targeting HSV glycoprotein D https://t.co/uTfVJhYXxC

[Dartmouth Engineering @thayerschool]

Study by Professor Margie Ackerman and Ackerman Lab/@GeiselMed students @mattslein and Iara Backes offers new insights on how antibodies combat HSV infections. This could lead to new treatments for neonatal herpes—one of the deadliest neonatal infections. https://t.co/FTYF6hmMDf

[Matt Slein @mattslein]

My first first-author paper of grad school is live on @CellRepMed https://t.co/LZ0HKXwzfc It was a labor of love resulting in a very interesting story on how antibodies protect neonatal mice from HSV infections

[Matt Slein @mattslein]

Happy New Year! Here's hoping this year brings good science without having to worry about money or whether or not I'll be homeless in 6 months!

[Natasha @KelkarNatasha]

My recent work as a PhD candidate in Ackerman lab is now online as a pre-print.
Thank you to all the co-authors for contributing to this study!

[Matt Slein @mattslein]

My first first-author paper of grad school is live as a preprint on @biorxivpreprint! Tweet thread to follow!

[bioRxiv Immunology @biorxiv_immuno]

Antibody effector functions are required for broad and potent protection of neonates from herpes simplex virus infection https://t.co/VtieQej4bw #biorxiv_immuno

[GOLD-UE @GOLDartmouth]

Our first bargaining session is today at 1PM EST! We are so excited to finally meet our employer at the table! Check your email for details on open bargaining.

[Matt Slein @mattslein]

@brianbest7799 If you’re at all interested in Dartmouth, I am happy to chat!

[Matt Slein @mattslein]

Not a bad place to learn how to code

[Matt Slein @mattslein]

Having a blast at #ASV2023 with the whole @dartmouth crew! Sad that the conference is nearly over.

[Matt Slein @mattslein]

Come see me talk about antibody-mediated protection and the HSV viral Fc Receptor at 3:45 today in Athena AB #ASV2023 #lovevirology

[American Society for Virology @AmerSocVirol]

Had some herpesvirologists stop by the ASV table. Go check out these posters and Paige’s lightning talk (W36-12)!